Company SymBio Pharmaceuticals Limited

4582

JP3383050006

Pharmaceuticals

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Holdings

Company contact information

Sector

Annual profits - Rate of surprise

Sector Other Pharmaceuticals

Delayed Japan Exchange Other stock markets 11:30:00 08/05/2024 am IST			5-day change	1st Jan Change
163 ^JPY	-4.12%		-6.32%	-34.01%

19/04	SymBio Pharmaceuticals Limited announced that it has received ¥196.35 million in funding from Evolution Capital Management LLC	CI
18/03	SymBio Pharmaceuticals Limited amended terms of the transaction	CI

SymBio Pharmaceuticals Limited is a Japan-based pharmaceutical company. Along with medicine specialists, contract research organizations (CROs) and other pharmaceutical companies, the Company is engaged in the design and operation of clinical tests, the manufacture and sale of new drugs specializing in three therapeutic areas: cancer, blood diseases and autoimmune diseases. The Company develops new medicines using chemical compounds proofed by preclinical tests and clinical tests. The Company manufactures and sells medicines through domestic and foreign pharmaceutical companies. The Company's pipelines include anticancer drugs, such as SyB L-0501, SyB L-1101 and SyB C-1101.

Number of employees: 109

JPY in Million	2022	Weight	2023	Weight	Delta
Pharmaceuticals 100.0 %	10,008	100.0 %	5,590	100.0 %	-44.15%

JPY in Million	2022	Weight	2023	Weight	Delta
Japan 100.0 %	10,008	100.0 %	5,590	100.0 %	-44.15%

Managers	Title	Age	Since
Fuminori Yoshida FOU	Founder	75	25/05/25
Takaaki Fukushima DFI	Director of Finance/CFO	-	-
Nkechi Mbanefo-Azie CTO	Chief Tech/Sci/R&D Officer	-	11/23/11
Hirotaka Ito COO	Chief Operating Officer	-	-
Koji Fukushima PRN	Corporate Officer/Principal	-	-

Members of the board	Title	Age	Since
Fuminori Yoshida FOU	Founder	75	25/05/25
Bruce David Cheson BRD	Director/Board Member	78	01/19/01
Shigetoshi Matsumoto BRD	Director/Board Member	74	01/17/01
Kesao Endo BRD	Director/Board Member	72	01/18/01
Eiji Ebinuma BRD	Director/Board Member	66	-

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	0	45,897,490	43,588,561 ( 94.97 %)	89,229 ( 0.1944 %)	94.97 %

Name	Equities	%	Valuation
Fuminori Yoshida 2.631 %	1,179,700	2.631 %	1 M ¥
Norihiro Kuroda 1.361 %	610,000	1.361 %	745 646 ¥
Sukenori Ito 0.9590 %	430,000	0.9590 %	525 619 ¥
Toshitaka Kashiwabara 0.4907 %	220,025	0.4907 %	268 952 ¥
Tsuguyuki Fujimoto 0.2699 %	121,000	0.2699 %	147 907 ¥
Teru Nishioka 0.2676 %	120,000	0.2676 %	146 684 ¥
Hiromi Toshishige 0.2583 %	115,800	0.2583 %	141 550 ¥
SYMBIO PHARMACEUTICALS LIMITED 0.1956 %	87,700	0.1956 %	107 202 ¥
DFA Australia Ltd. 0.005061 %	2,269	0.005061 %	2 774 ¥

Name	Equities	%	Valuation
SYMBIO PHARMACEUTICALS LIMITED 0.20%	87,700	0.20%	107,202 $

SymBio Pharmaceuticals Ltd.

Toranomon 30 Mori Building 3-2-2 Toranomon

105-0001, Tokyo

http://www.symbiopharma.com

address SymBio Pharmaceuticals Limited(4582)

Company calendar

Healthcare

Pharmaceuticals & Medical Research

Pharmaceuticals

Pharmaceuticals

Other Pharmaceuticals

	1st Jan change	Capi.
SYMBIO PHARMACEUTICALS LIMITED	-34.01%	50.41M
ELI LILLY AND COMPANY	+32.95%	700B
JOHNSON & JOHNSON	-4.97%	358B
MERCK & CO., INC.	+18.83%	330B
ABBVIE INC.	+3.54%	287B
ASTRAZENECA PLC	+15.70%	236B
NOVARTIS AG	+6.68%	202B
ROCHE HOLDING AG	-9.08%	197B
AMGEN INC.	+6.70%	161B
PFIZER, INC.	-1.81%	157B

Other Pharmaceuticals